, FRCS, FRCOG, FRANZCOG, DPhil(Oxon) BACKGROUND: Small-for-gestational-age infants (birthweight <0th centile) are at increased risk of perinatal complications but are frequently not identified antenatally, particularly in low-risk women delivering at term (37 weeks gestation). This is compounded by the fact that late pregnancy ultrasound is not the norm in many jurisdictions for this cohort of women. We thus investigated the relationship between birthweight <10th centile and serious neonatal outcomes in low-risk women at term. OBJECTIVE(S): We aimed to determine whether there is a difference of obstetric and perinatal outcomes for small-for-gestational-age infants, subdivided into fifth to <10th centile and less than the fifth centile cohorts compared with an appropriate-for-gestational age (birthweight 10the90 th centile) group at term. STUDY DESIGN: This was a retrospective analysis of data from the Mater Mother's Hospital in Brisbane, Australia, for women who delivered between January 2000 and December 2015. Women with multiple pregnancy, diabetes mellitus, hypertension, preterm birth, major congenital anomalies, and large for gestational age infants (>90th centile for gestational age) were excluded. Small-for-gestational-age infants were subdivided into 2 cohorts: infants with birthweights from the fifth to <10th centile and those less than the fifth centile. Serious composite neonatal morbidity was defined as any of the following: Apgar score 3 at 5 minutes, respiratory distress syndrome, acidosis, admission into the neonatal intensive care unit, stillbirth, or neonatal death. Univariate and multivariate analyses were performed using generalized estimating equations to compare obstetric and perinatal outcomes for small-for-gestational-age infants compared with appropriate-for-gestational age controls. RESULTS: The final study comprised 95,900 infants. Five percent were between the fifth and <10th centiles for birthweight and 4.3% were less than the fifth centile. The rate of serious composite neonatal morbidity was 11.1% in the control group, 13.7% in the fifth and <10th centile, and
22.6% in the less than the fifth centile cohorts, respectively. Even after controlling for confounders, both the fifth to <10th centiles and less than the fifth centile cohorts were at significantly increased risk of serious composite neonatal morbidity compared with controls (odds ratio, 1.25, 95% confidence interval, 1.15e1.37, and odds ratio, 2.20, 95% confidence interval, 2.03e2.39, respectively). Infants with birthweights <10th centile were more likely to have severe acidosis at birth, 5 minute Apgar score 3 and to be admitted to the neonatal intensive care unit. The serious composite neonatal morbidity was higher in infants less than the fifth centile compared with those in the fifth to <10th centile cohort (odds ratio, 1.71, 95% confidence interval, 1.52e1.92). The odds of perinatal death (stillbirth and neonatal death) were significantly higher in both smallfor-gestational age groups than controls. After stratification for gestational age at birth, the composite outcome remained significantly higher in both small-for-gestational-age cohorts and was highest in the less than the fifth centile group at 37þ0 to 38þ6 weeks (odds ratio, 3.32, 95% confidence interval, 2.87e3.85). The risk of perinatal death was highest for infants less than the fifth centile at 37þ0 to 38þ6 weeks (odds ratio, 5.50, 95% confidence interval, 2.33e12.98). CONCLUSION: Small-for-gestational-age infants from term, low-risk pregnancies are at significantly increased risk of mortality and morbidity when compared with appropriate-for-gestational age infants. Although this risk is increased at all gestational ages in infants less than the fifth centile for birthweight, it is highest at early-term gestation. Our findings highlight that early-term birth does not necessarily improve outcomes and emphasize the importance of identifying this cohort of infants.
C ompared with preterm cohorts, overall perinatal complications in term small-for-gestational-age (SGA) infants (defined as birthweight <10th centile for gestation) are lower and tend to be at the milder end of the spectrum. 1, 2 In high-income countries, >60% of nonanomalous SGA births occur at term with evidence that, compared with appropriate-forgestational-age (AGA) controls, reduced birthweight is associated with an increased risk of morbidity and mortality. 3, 4 The increased risk is partly due to the proportion of SGA infants that are truly growth restricted secondary to placental dysfunction. Indeed, in low-risk pregnancies, placental malperfusion and dysfunction account for a populationattributable risk of 25% for SGA infants. 5 Clinical identification of SGA fetuses late in pregnancy is difficult, with physical examination and symphysis fundal height assessment limited by a number of factors including maternal habitus and fetal lie. Furthermore, unlike women with known risk factors (hypertension, diabetes mellitus, previous fetal growth restriction, etc), routine ultrasound to assess fetal growth is generally not performed in low-risk women unless there are concerns about fetal size on clinical examination.
From a health care burden perspective, the vast majority of SGA infants are born at term, 6 often from uncomplicated, low-risk pregnancies. The difficulty, however, is defining what constitutes a low-risk cohort because there are many maternal medical, demographic, and psychosocial factors that are associated with an increased risk of adverse outcomes. Clearly if this population were to be defined by the absence of all possible risk factors, this would result in an artificially low number of women who would be considered normal or low risk. Such an approach would be divorced from clinical reality. Notwithstanding the difficulty in defining this cohort, some investigators have suggested that excluding women with diabetes mellitus and hypertension is reasonable, given their relatively high prevalence in pregnancy. 4 The aim of this study thus was to analyze obstetric and perinatal outcomes of term SGA infants from a contemporary, low-risk Australian cohort. More specifically, the objectives were to evaluate outcomes for infants with birth weight less than the fifth centile and fifth to <10th centiles stratified for gestational age at birth (37þ0 weeks to 38þ6 weeks, 39þ0 weeks to 40þ6 weeks, and 41 weeks).
Materials and Methods
This was a retrospective cohort study of women who delivered between January 2000 and December 2015 at the Mater Mother's Hospital in Brisbane, Australia, using previously prospectively collected data. Maternal demographic, intrapartum, and perinatal outcome information was collected from the hospital's maternity database and crossreferenced with the maternal and fetal medicine and neonatal databases to ensure robust data ascertainment.
The Mater Mother's Hospital is a major tertiary center in Queensland with a birth rate of approximately 10,500 per annum, making it the largest maternity hospital in Australia. Approval for this study was granted by the institution's Human Research Ethics Committee (reference number HREC/14/MHS/37).
We included all women with nonanomalous singleton, term pregnancies with a recorded birthweight. Gestational age was calculated using the last menstrual period or earliest ultrasound examination or by correlation of both. Birthweight centiles were calculated with reference to previously published Australian standards. 7 AGA was defined as a birthweight of 10th to 90th centile. The SGA cohort was subdivided into 2 categories: SGA1 (birthweight fifth to <10th centiles) and SGA2 (birthweight less than the fifth centile). Women with multiple gestations, diabetes mellitus (either preexisting or gestational), hypertension (either preexisting, pregnancy induced, or preeclampsia), congenital fetal malformations, and preterm birth (<37 weeks) were excluded.
Demographic data analyzed included maternal age, ethnicity (white, Asian, indigenous, or other), parity, marital status, smoking status, alcohol consumption, and body mass index (BMI). Indigenous ethnicity was defined as women who identified as being of aboriginal or Torres Strait Islander origin. Intrapartum outcomes collected included onset of labor (induced or spontaneous) and mode of birth (spontaneous vaginal delivery, instrumental, elective cesarean, emergency cesarean for nonreassuring fetal status, or emergency cesarean for other indications). A univariate analysis was first performed to identify significant potential confounders.
Neonatal outcomes analyzed included gestational age at birth, birthweight, Apgar score 3 at 5 minutes, presence of significant respiratory distress (as defined by the attending neonatologist), perinatal death, neonatal death, stillbirth, acidosis at birth, and admission to the neonatal intensive care unit (NICU). Perinatal death was defined as stillbirths and neonatal death combined. Only stillbirths confirmed to have occurred 37 weeks' gestation were included in the analysis.
Neonatal death was defined as death within 28 days of birth. Acidosis was defined as cord pH <7, lactate 6 mmol/L, or cord base excess e12 mmol/L. Serious composite neonatal morbidity (SCNM) was defined as any of the following: Apgar score 3 at 5 minutes, respiratory distress syndrome, acidosis, admission into the NICU, stillbirth, or neonatal death.
Statistical analysis
Data integrity was assessed using a year-by-year analysis to identify inconsistencies of reporting between years. Where data integrity was questionable with sudden drops in outcomes that could not be accounted for by change in policy or treatment, those variables were excluded from any analysis. Efforts were made to correct missing and data entry errors through searches of individual patient records. Where data were collected with different degree of outcomes between years, these variables were collapsed into dichotomous variables to indicate whether the outcome occurred. Where only the outcomes were recorded, after discussion with data custodians, it was determined that it was reasonable to assume that missing data indicated that the outcome had not occurred.
Descriptive analysis was performed using Mann-Whitney U tests for continuous variables and categorical variables compared using a c 2 test. All continuous variables were tested for normality using a Shapiro-Wilk W test and deemed to be nonnormally distributed. Subsequently data are reported as median (interquartile range) or as the number of observations with the percentage of the total.
A univariate and multivariate analysis was performed using generalized estimating equations to adjust for the correlation between mothers who delivered more than once within the study period. Multivariate analysis was adjusted for sex, maternal age, BMI at delivery, ethnicity, parity, smoking status, and mode of birth. All statistical analyses were conducted using StataCorp 2015 (Stata Statistical Software, release 14; StataCorp LP, College Station, TX).
Results
Between 2000 and 2015, there were 137,398 women who delivered at the Mater Mother's Hospital. After excluding 41,498 women, the final cohort ( Figure) comprised of 95,900 women and infant dyads. Infants with birthweights fifth to <10th centiles (SGA1) and less than the fifth centile (SGA2) constituted 5.0% (4748 of 95,900) and 4.3% (4135 of 95,900) of the total cohort, respectively.
Both the SGA1 and SGA2 cohorts were found to significantly differ from the AGA cohort with respect to maternal age, ethnicity, parity, marital status, smoking status, and maternal BMI. They were more likely to be young (maternal age <20 years), to be of Asian, indigenous, and other ethnicity, to be nulliparous, and to smoke and less likely to be married and obese. When the SGA1 and SGA2 cohorts were compared, the odds of maternal age <20 years, Asian and indigenous ethnicity, nulliparity, and smoking status were higher in the SGA2 cohort (Table 1) .
For intrapartum outcomes, both the SGA1 and SGA2 cohorts were significantly more likely than the AGA cohort to have an instrumental or emergency cesarean for nonreassuring fetal status (fetal distress). The odds of requiring induction of labor was higher in the SGA2 compared with the AGA cohort and higher in the SGA2 compared with the SGA1 group. The odds of spontaneous vaginal delivery were, however, lower in the SGA2 cohort when compared with both the AGA and the SGA1 cohorts (Table 2) .
There was no difference in median gestation at birth for either of the SGA subcohorts compared with the AGA controls. The odds of severe acidosis at birth, very low (3) 5 minute Apgar score, and NICU admission were significantly higher in the SGA1 and SGA2 cohorts, even after controlling for confounders (sex, maternal age and BMI, parity, ethnicity, smoking, and mode of birth). The odds of stillbirth or neonatal death were, however, not different between the SGA1 and SGA2 cohorts. The odds of SCNM was highest in the SGA2 cohort (odds ratio [OR], 2.20, 95% confidence interval [CI], 2.03e2.39) compared with the AGA controls. The odds of the SCNM was also higher in the SGA2 compared with the SGA1 cohort (OR, 1.71, 95% CI, 1.52e1.92) ( Table 3) .
The risk of perinatal death (stillbirth and neonatal death) was substantially higher in both SGA cohorts compared with the control group. The SGA1 Data are presented as n (percentage), univariate odds ratio (95% confidence interval).
AGA, appropriate for gestational age (birthweight 10th to 90th centile); BMI, body mass index; SGA, small for gestational age (birthweight <10th centile for gestational age); SGA1, birthweight fifth to <10th centiles for gestational age; SGA2, birthweight less than the fifth centile for gestational age.
a P < .001; b P < .01. Table 3) . Following stratification of neonatal outcomes by gestational age, the odds of SCNM remained significantly increased in both SGA groups compared with controls. The SGA2 cohort had higher odds of SCNM than the SGA1 cohort at 37þ0 to 38þ6 weeks (OR, 2.48, 95% CI, 2.02e3.04) and at 39þ0 to 40þ6 weeks (OR, 1.54, 95% CI, 1.30e1.83). For both cohorts, the odds of NICU admission was highest at early term (37þ0 to 38þ6 weeks) and subsequently decreased with rising gestation. The odds of stillbirth (OR, 5.40, 95% CI, 1.96e14.83) and overall perinatal death (OR, 5.50, 95% CI, 2.33e12.98) was highest in the SGA2 cohort at 37þ0 to 38þ6 weeks (Table 4) .
Comment

Principal findings
The results from this large Australian study demonstrates that in low-risk pregnancies, outcomes for SGA infants born at term are significantly worse compared with an AGA cohort. Specifically, newborns with a birthweight less than the fifth centile (SGA2) had a doubling of the SCNM (22.6% vs 11.1%), while infants with a birthweight from the fifth to the 10th centile (SGA1) had 23% increase (13.7% vs 11.1%) in adverse outcomes.
Regression analyses to control for confounders showed that the SCNM was >2-fold higher in the SGA2 cohort. We also found that, although the risk of SCNM was greatest at early term gestation, regardless of SGA subcohort, this risk remained elevated, even at term and postterm gestation. Importantly, our results indicate that the risk of stillbirth was >5-fold and >3-fold at early term Our findings also show that the odds of emergency cesarean for nonreassuring fetal status was significantly greater in both the SGA1 and SGA2 cohorts, with the highest odds in the SGA2 cohort. This is an important finding, given that there is significant neonatal morbidity (neonatal encephalopathy, respiratory distress, acidosis, admission to the neonatal intensive care unit) associated with intrapartum hypoxia. Furthermore, rapid delivery by emergency cesarean for nonreassuring fetal status is associated with poorer neonatal outcomes compared with uncomplicated vaginal birth. 8 In Australia, emergency cesarean rates for fetal distress range from 11% to 16%, 9 reflecting trends seen in other high-income countries. Alongside the increased risk of perinatal death, the possibility of hypoxia-related, braininjured individuals requiring a lifetime of care, intrapartum fetal compromise continues to represent a major burden for health care providers around the world, with SGA infants a particularly vulnerable cohort for this specific complication.
Our study represents the largest cohort study published to date investigating serious neonatal outcomes in a population without major risk factors (hypertension and diabetes mellitus) for aberrant fetal growth. Collectively, our findings and that of 2 other recent large publications from North America, 4, 10 including one published in an earlier issue of this Journal, 4 provide robust evidence of the perinatal risks that pregnancies with SGA infants face, even at term. Furthermore, when identification of SGA infants is made on the basis of ultrasound measurements, the odds of perinatal morbidity is more than doubled in infants with an estimated fetal weight less than the fifth centile, regardless of whether the SGA diagnosis is made in early third trimester or within AGA, appropriate for gestational age (birthweight 10th to 90th centile); SGA, small for gestational age (birthweight <10th centile for gestational age);
SGA1, birthweight fifth to <10th centile for gestational age; SGA2, birthweight less than the fifth centile for gestational age; NICU, neonatal intensive care unit; SCNM, serious composite neonatal morbidity a P < .05;
Adjusted odds ratio (95% confidence intervals), adjusted for sex, maternal age and BMI, ethnicity, parity, smoking status, and mode of birth.
Madden et al. Small for gestational age infants at term gestation and serious neonatal outcomes. Am J Obstet Gynecol 2018.
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Given that such women make up the majority of pregnancies in most jurisdictions, 6 the imperative for prenatal identification of SGA fetuses is obvious because it is now clear that, regardless of gestation, overall perinatal outcomes for SGA infants are worse compared with their appropriately grown counterparts, and this dichotomy is even more pronounced if fetal growth restriction is present. 12, 13 Additionally, the risk of term perinatal death is substantially increased, with low birthweight 3 further underlining the critical importance of prenatal identification, given that early term delivery could be one potential strategy of mitigating this risk, notwithstanding the potential neonatal morbidity associated with this option.
The evidence regarding ultrasound detection of SGA fetuses is confusing and conflicting, with some studies showing a lack of benefit 14, 15 and others demonstrating detection rates >50%.
16-18
Furthermore, Cochrane reviews do not demonstrate an advantage with the use of either routine late-pregnancy ultrasound or umbilical artery Doppler assessment in low-risk populations. 19, 20 Moreover, it is also unclear whether a single late pregnancy measurement of fetal biometry or assessment of growth velocity is superior for the identification of an SGA fetus.
A recent study from North America found that there was no difference in SGA detection rates when single biometry was compared with serial measurements, with only modest impact on screening performance when maternal risk factors including diabetes mellitus and hypertension were accounted for. 21 This study also demonstrated that fetal biometry measured within 2 weeks of predetermined gestational age cutoffs (<32 weeks and <36 weeks) did not improve detection rates for SGA fetuses.
Conversely, another study showed that although third-trimester biometry provided poor to moderate detection of SGA fetuses, a shorter compared with a longer ultrasound to delivery interval provided better prediction. 22 Others ultrasound studies have suggested that [23] [24] [25] [26] [27] A low CPR, particularly in SGA fetuses, is associated with an increased risk of stillbirth 28 and other adverse perinatal outcomes. 29 It also appears to be an independent predictor of intrapartum fetal compromise, acidosis at birth, and neonatal unit admission in term infants.
30,31
Although a recent review comparing planned early delivery with expectant management at term for suspected fetal compromise failed to show a difference in perinatal mortality, neonatal morbidity, or neurodevelopment disability, 32 there is emerging evidence to suggest that when accompanied by careful surveillance and planned delivery, rates of adverse outcomes in SGA infants can be reduced. 33 Currently the American Congress of Obstetricians and Gynecologists recommends delivery by 39 weeks for infants with fetal growth restriction without other risk factors, 12 whereas the Royal College of Obstetricians and Gynaecologists in the United Kingdom recommend delivery by 37 weeks. 34 This difference in recommendations for timing of delivery reflects the paucity of good data to guide management. The results from our study, however, would support a policy of deferring delivery of SGA infants in a low-risk cohort of women until 39þ0 weeks.
The main limitations of this study relate to its retrospective nature and its single-institution focus. We also used population charts rather than customized ones when defining our cohorts. In our view this approach was, however, resonable, given the data from the Intergrowth-21st 35 and other studies 36 suggesting that customized charts were not superior in identifying infants at risk of adverse outcomes. We, however, acknowledge that although some investigators 37 suggest that the use of customized charts better identifies SGA infants, others urge caution, 38 noting that detection rates are no different, whatever charts are used. Furthermore, whereas it is clear that the risk of adverse outcomes is maximum at extremes of size, 2 the incremental risk appears to commence at higher birthweight centiles than the cutoffs we have chosen. 39 We were also not able to ascertain the number of women in whom there were antenatal concerns and had increased surveillance of well-being. As a consequence of this, we were unable to establish the proportion of women who had planned birth (induction of labor or cesarean) because of either clinical concerns regarding fetal size or an ultrasound-confirmed SGA fetus.
Additionally, data regarding socioeconomic status, prenatal education, specific intrapartum (chorioamnionitis, abruption etc), and neonatal complications (necrotising enterocolitis, etc) were not consistently or reliably recorded and hence not reported in this study.
The strengths of our study include the very large sample size from a tertiary institution with clear evidence-based protocols guiding management providing a real-world view of outcomes. Furthermore, it is unlikely that our results were influenced by a Hawthorne effect, given that all patient data were collected contemperaneously in the absence of enrollment of participants in any clinical studies. We also chose components of the composite morbidity to reflect not only very poor condition at birth (Apgar 3 and severe acidosis, severe respiratory distress, and admission to the NICU) but also mortality (stillbirth and neonatal death).
Conclusions and implications for clinical practice
In conclusion, the results presented in this paper provide further evidence that SGA infants from term uncomplicated pregnancies have significantly increased morbidity and mortality rates when compared with AGA infants, with the greatest risk seen in infants less than the fifth centile, regardless of gestation at birth. The evidence for increased morbidity and mortality seen in SGA infants both in this and other studies in our view highlights the importance of prenatal identification of this group.
Although the optimum management algorithm after detection is yet to be determined, identification of a vulnerable cohort such as this allows potentially closer surveillance as well as a comprehensive discussion with women regarding ongoing risks and all management options including early term birth, induction of labor, or planned cesarean.
Our findings also support the need for large randomized controlled studies to ascertain first the optimum screening gestation and technique for SGA fetuses (single late pregnancy ultrasound, serial biometry measurements, and/or incorporating the fetal CPR, placental biomarkers, etc), and second the optimum gestation for delivery to mitigate this risk.
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